KRYS Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Krystal Biotech Inc

Watchlist Manager

Watchlist

Price: 334.81 USD -0.07%

Market Cap: $9.9B

	Krystal Biotech Inc NASDAQ:KRYS	US
	Dios Fastigheter AB STO:DIOS	SE
	Assicurazioni Generali SpA F:ASG0	IT
D	Dominion Energy Inc DUS:DOD	US
M	Marubeni Corp F:MARA	JP
S	Square Enix Holdings Co Ltd F:EI4	JP
D	Deutsche Bank AG DUS:DBK	DE
Z	Z Holdings Corp OTC:YAHOY	JP
N	Netflix Inc DUS:NFC	US

Profitability Summary

Krystal Biotech Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

95%

Strong 3Y Average Gross Margin

94%

Declining Gross Margin

97% > 95%

Exceptional Operating Margin

45%

Negative 3Y Average Operating Margin

-126%

Operating Margin is Increasing

-1 579% > 45%

Exceptional Net Margin

55%

Sustainable 3Y Average Net Margin

12%

Net Margin is Increasing

-348% > 55%

Exceptional Free Cash Flow Margin

59%

Negative 3Y Average Free Cash Flow Margin

-108%

Free Cash Flow Margin is Increasing

-1 391% > 59%

Positive ROE

20%

Positive 3Y Average ROE

Positive 3Y Average ROIC

11%

ROIC is Increasing

-68% > 38%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.